Desalting and Buffer Exchange Market Overview:
The Desalting and Buffer Exchange Market is projected to reach USD 1.4 Billion by 2032 at 10.2% CAGR during the forecast period 2023-2032. Desalting is a method for separating soluble low molecular weight compounds from nucleic acid and protein samples. Buffer exchange, on the other hand, is the process of replacing one set of buffer salts with another.
Furthermore, buffer exchange is an important step in the processing of biological samples, since it prepares the material for downstream uses. In recent years, the worldwide desalting and buffer exchange sector have seen tremendous expansion. Furthermore, factors such as increased research and development investment by major biopharmaceutical firms, as well as a growing focus on proteomic and genomic research, are expected to support market growth throughout the forecast period.
The Desalting and Buffer Exchange Market has been segmented into technique, product, and application. On the basis of technique, the market has been segmented into filtration, chromatography, and precipitation. The filtration segment has been further segmented into ultrafiltration and dialysis. The chromatography segment has been segmented into size-exclusion chromatography and others.
The market, by product, has been segmented into kits, cassettes, filter plates, spin columns, membrane filters, and others.
The market, by application, has been segmented into bioprocess applications and diagnostic applications. The bioprocess segment is expected to account for the largest market share in 2017. The market growth of the segment is attributed to the increasing demand for biopharmaceutical products.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The desalting and buffer exchange market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.
The European desalting and buffer exchange market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The desalting and buffer exchange market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The desalting and buffer exchange market in the Middle East & Africa has been segmented into the Middle East and Africa.
Merck KGaA, GE Healthcare, Sartorius AG, Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Avantor, Repligen Corporation, Bio-works Technologies Ab, Phynexus, Inc., and Norgen Biotek Corp. are some of the key players in the desalting and buffer exchange market.
Regional Market Summary
Global Desalting and Buffer Exchange Market Share (%), by Region, 2017
Source: Office of National Statistics, White Papers, Company Presentations, Annual Reports
Geographically, the Americas is anticipated to dominate the desalting and buffer exchange market owing to the rising demand for biopharmaceuticals, rising R&D expenditure by biopharmaceutical companies, and increasing research activities in the field of genomics and proteomics.
Europe is expected to hold the second largest position in the desalting and buffer exchange market. The market growth in this region is attributed to the increasing number of research and development activities in the region.
The desalting and buffer exchange market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be the fastest growing region owing to the continuously growing biotechnology sector and increasing regional expansion by prominent market players.
The Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to a well-developed healthcare sector and growing government initiatives for the healthcare sector.Recent Development
Agilent Technologies, Inc. (Agilent or 'the firm') provides equipment, software, services, and consumables that enable clients in the clinical and life sciences research fields to identify, analyze, and measure the biological and physical characteristics of substances and products. Pharmaceutical and biopharmaceutical companies, academia and government, chemical and energy companies, environmental and forensics companies, diagnostics and clinical companies, and food companies all use the company's services. California is the company's headquarters.
PhyNexus, Inc., a privately owned California firm, said today that it has agreed to be purchased by Biotage AB (Nasdaq Stockholm: BIOT.ST), enhancing its position in the global sales and marketing of automated lab-scale biomolecule purification technology. PhyNexus and Biotage will be able to provide its worldwide clients a platform based on Dual Flow Chromatography and unique tip technology for high throughput purification of biomolecules such as proteins, plasmids, and antibodies at the lab scale.
Desalting and Buffer Exchange Market, by Technique
- Size-Exclusion Chromatography
Desalting and Buffer Exchange Market, by Product
- Cassettes & Cartridges
- Filter Plates
- Spin Columns
- Membrane Filters
Desalting and Buffer Exchange Market, by Application
- Bioprocess Applications
- Diagnostic Applications
Desalting and Buffer Exchange Market, by Region
- North America
- South America
- Western Europe
- Rest of Western Europe
- Eastern Europe
- South Korea
- Rest of Asia-Pacific
- Filtration and chromatography manufacturers, and distributors
- Research and consulting firms
- Pharmaceutical and biotechnology manufacturers
- Contract research organizations (CROs)
- Contract manufacturing organizations (CMOs)
USD 1.4 Billion
Value (USD Million)
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Technique, Product, and Application
North America, Europe, Asia-Pacific, and Rest of the World (RoW)
Merck KGaA, GE Healthcare, Sartorius AG, Thermo Fisher Scientific, Danaher Corporation, Agilent Technologies, Inc., Bio-Rad Laboratories, Avantor, Repligen Corporation, Bio-works Technologies Ab, Phynexus, Inc., and Norgen Biotek Corp.
Key Market Opportunities
New product launches and R&D Amongst major key Players
Key Market Drivers
Growing demand for monoclonal antibodies
Increasing research and development expenditure by the biopharmaceutical companies
Growing focus on proteomic and genomic research
Frequently Asked Questions (FAQ) :
The desalting and buffer exchange market is projected to grow at a 10.2% CAGR between 2023-2032.
The Americas is projected to command the largest share in the desalting and buffer exchange market.
The bioprocess segment will have the largest share in the desalting and buffer exchange market.
Increasing R&D expenditure and demand for monoclonal antibodies are boosting market growth.
Lack of skilled professionals may limit market growth.
Key Questions Answered
Request Free Sample
- ✅Global Market Outlook
- ✅In-depth analysis of global and regional trends
- ✅Analyze and identify the major players in the market, their market share, key developments, etc.
- ✅To understand the capability of the major players based on products offered, financials, and strategies.
- ✅Identify disrupting products, companies, and trends.
- ✅To identify opportunities in the market.
- ✅Analyze the key challenges in the market.
- ✅Analyze the regional penetration of players, products, and services in the market.
- ✅Comparison of major players’ financial performance.
- ✅Evaluate strategies adopted by major players.
Why Choose Market Research Future?
Speak to Analyst
- ✅Vigorous research methodologies for specific market.
- ✅Knowledge partners across the globe
- ✅Large network of partner consultants.
- ✅Ever-increasing/ Escalating data base with quarterly monitoring of various markets
- ✅Trusted by fortune 500 companies/startups/universities/organizations
- ✅Large database of 5000+ markets reports.
- ✅Effective and prompt pre- and post-sales support.